Value
1.3/10data confidence 20%| Component | Sub-score |
|---|---|
| P/E | 1.3 |
- ▸Expensive valuation
NNNN · Why this verdict
Why Anbio Biotechnology (NNNN) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The business shows excellent returns on equity of 27%, strong margins of 74%, and is described as having a wide economic moat with compounder-quality characteristics of strong returns plus growth. Quality breakdown | Margins and return on equity should remain elevated and the moat characterization should hold over the next 12 months. | →Stable |
| CounterThe same quality read is undercut by an earnings-quality red flag, since free cash flow is running negative relative to net income, so the reported profitability may not be converting into cash. | ||
Free cash flow is negative relative to net income, an earnings-quality red flag despite the otherwise strong reported margins. Quality breakdown | Free cash flow should turn positive relative to net income over the next 12 months, resolving the earnings-quality concern. | →Stable |
| CounterA period of negative free cash flow conversion can be a temporary function of working-capital timing rather than a durable divergence between reported earnings and cash generation. | ||
Revenue is growing strongly at 74% year over year. Growth breakdown | Revenue growth should remain at or above a strong double-digit pace over the next 12 months. | →Stable |
| CounterVery high growth rates against a small base are difficult to sustain, and the business simultaneously fails the combined growth-and-profitability Rule of 40 test, suggesting the growth may not be efficiently monetized. | ||
Despite the quality and growth profile, the stock is flagged as expensively valued, with the value score near the bottom of the scale. Valuation breakdown | The valuation should compress to a more reasonable level, with the value score rising off its current low, over the next 12 months. | →Stable |
| CounterA premium multiple can be justified indefinitely by a business with a wide moat and strong compounding characteristics, especially one growing revenue at 74%. | ||
The stock is in a confirmed downtrend, trading below its 200-day moving average with the average sloping down 12.5% over the past 30 days, and the momentum gate failed at 3.7 versus the 4.5 threshold, triggering a death-cross hard block. Momentum breakdown | Price should reclaim the 200-day moving average, the moving-average slope should turn positive, and momentum should climb back above 4.5 over the next 12 months. | →Stable |
| CounterA technical trend flip can occur quickly if the underlying growth story reasserts itself, especially since the stock is already down sharply from its highs. | ||
The business shows excellent returns on equity of 27%, strong margins of 74%, and is described as having a wide economic moat with compounder-quality characteristics of strong returns plus growth.
→StableQuality breakdown
- Expectation
- Margins and return on equity should remain elevated and the moat characterization should hold over the next 12 months.
CounterThe same quality read is undercut by an earnings-quality red flag, since free cash flow is running negative relative to net income, so the reported profitability may not be converting into cash.
Free cash flow is negative relative to net income, an earnings-quality red flag despite the otherwise strong reported margins.
→StableQuality breakdown
- Expectation
- Free cash flow should turn positive relative to net income over the next 12 months, resolving the earnings-quality concern.
CounterA period of negative free cash flow conversion can be a temporary function of working-capital timing rather than a durable divergence between reported earnings and cash generation.
Revenue is growing strongly at 74% year over year.
→StableGrowth breakdown
- Expectation
- Revenue growth should remain at or above a strong double-digit pace over the next 12 months.
CounterVery high growth rates against a small base are difficult to sustain, and the business simultaneously fails the combined growth-and-profitability Rule of 40 test, suggesting the growth may not be efficiently monetized.
Despite the quality and growth profile, the stock is flagged as expensively valued, with the value score near the bottom of the scale.
→StableValuation breakdown
- Expectation
- The valuation should compress to a more reasonable level, with the value score rising off its current low, over the next 12 months.
CounterA premium multiple can be justified indefinitely by a business with a wide moat and strong compounding characteristics, especially one growing revenue at 74%.
The stock is in a confirmed downtrend, trading below its 200-day moving average with the average sloping down 12.5% over the past 30 days, and the momentum gate failed at 3.7 versus the 4.5 threshold, triggering a death-cross hard block.
→StableMomentum breakdown
- Expectation
- Price should reclaim the 200-day moving average, the moving-average slope should turn positive, and momentum should climb back above 4.5 over the next 12 months.
CounterA technical trend flip can occur quickly if the underlying growth story reasserts itself, especially since the stock is already down sharply from its highs.
TrendMatrix Research · core thesis
Engine thesis — one sentence
This is a high-quality compounder with a wide moat and 74% revenue growth, but an earnings-quality red flag from negative free cash flow, an expensive valuation, and a confirmed technical downtrend with a death-cross gate failure argue for reducing exposure.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 9.0 |
| ROA | 9.8 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 5.0 |
| FCF quality | 0.0 |
| Moat | 8.0 |
| Rule of 40 | 3.0 |
| Piotroski F | 6.7 |
- ▸Excellent ROE: 27%
- ▸Strong margins: 74%
- ▸Earnings quality RED FLAG: -150% FCF/NI
- ▸Wide economic moat
Growth
10.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
- ▸Strong growth: 74% YoY
Momentum
2.3/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 3.1 |
| OBV | 1.0 |
| MA position | 1.0 |
| Volume | 3.5 |
- ▸Capitulation risk (RSI 14, below 200MA)
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA, MA slope -14.1%/30d — confirmed downtrend
Sentiment
5.6/10data confidence 67%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.2 |
| Analyst rating | 5.0 |
Insider
5.0/10data confidence 50%Peer rank
6.1/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.6 |
| quality rank | 9.5 |
| growth rank | 9.3 |
- ▸Superior ROE vs peers
- ▸Best-in-class margins
Technical
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 10.0 |
| support resistance | 8.9 |
| 52w position | 0.0 |
| gap | 6.0 |
Risk (lower is worse)
5.9/10data confidence 60%| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 7.8 |
| volatility | 0.0 |
Catalyst
6.0/10data confidence 25%| Component | Sub-score |
|---|---|
| news activity | 6.0 |
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (6)
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:2.3<4.5
- DEATH_CROSS:HARD_BLOCK
Warning (1)
- ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
15.0%
Sizing output
AVOID
SetupFalling Knife — Death cross, below all MAs, RSI 14, MACD bearish
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Drawdown -83% (>40% off 52w high)
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: INSIDER:OK. Top dim: Growth at 10.0; weakest: Value at 1.3. No conviction either direction.
The strongest dimensions are Growth at 10.0, Quality at 7.2, and Technical at 6.2; the weakest are Value at 1.3, Momentum at 2.3, and Insider at 5.0. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1High Quality Compounder Wide Moat
Trip ifReturn on equity falls below 10% from the current 27%.
- P2Strong Revenue Growth
Trip ifRevenue growth falls below 20% YoY from the current 74%.
- P3Expensive Valuation Risk
Trip ifThe value score rises above 5.0 from the current 0.8, indicating the valuation has compressed.
- P4Confirmed Downtrend Death Cross
Trip ifThe momentum score rises above 4.5 from the current 3.7, and the 200-day moving-average slope turns positive.
- P5Negative Free Cash Flow Earnings Quality
Trip ifFree cash flow to net income turns positive, rising above 0% from the current -150%.